ArticleOncotarget2015

T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.

Houda Alachkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.